U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Cefotaxime Sodium Injection
Status: Currently in Shortage
»Date first posted: 02/17/2015
»Therapeutic Categories: Anti-Infective; Pediatric

Expand all

Hikma Pharmaceuticals USA, Inc. (Reverified 07/01/2024)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Cefotaxime for Injection, USP, Injection, 500 mg (NDC 0143-9930-10) Unavailable On backorder. Shortage duration is unknown at this time. Demand increase for the drug
Cefotaxime for Injection, USP, Injection, 1 g (NDC 0143-9931-25) Unavailable On backorder. Shortage duration is unknown at this time. Demand increase for the drug
Cefotaxime for Injection, USP, Injection, 2 g (NDC 0143-9933-25) Unavailable Shortage duration is unknown at this time. Demand increase for the drug
Cefotaxime for Injection, USP, Injection, 10 g (NDC 0143-9935-01) Unavailable Shortage duration is unknown at this time. Demand increase for the drug

SteriMax, Inc. (Revised 03/15/2024)

Company Contact Information:
800-881-3550

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Cefotaxime, Injection, 2 g (NDC 21586-012-02) Available

Dear Healthcare Professional Letter

Injection, 1 g (NDC 21586-011-02) Available

Dear Healthcare Professional Letter

Back to Top